August 1, 2022
Not sure when we started calling this the wacky world of diabetes, but the phrase is very appropriate and continues to be proven each day. Today’s wacky items include
1. Dexcom shares recover from sell off.
2. Insulet announces full market release of Omnipod 5.
3. Tandem, Lilly, Novo Nordisk and Insulet all report this week.
As we write shares of Dexcom are up nearly 4% which we anticipated. The company reported results last week and once again the street wasn’t thrilled. (And just as FYI any company that is run to please the street is not a . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.